MoneyWorks4Me

Lupin aims to launch new products across globe in current fiscal

15 Jul 2019 Evaluate

Lupin is aiming to launch its first biosimilar product and commercialize its first inhalation product in the US in the current fiscal. The new launches across the globe would help it achieve sustainable growth.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..